12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus, Type 2

In brief

The purpose of this Phase 2a study is to evaluate the efficacy, safety and tolerability, of multiple parallel doses of PF-00734200 following oral administration to adult human subjects with T2DM who currently are on a stable dose of metformin.

Key facts

Study ID

NCT00473525

Run by

Pfizer

People needed

303

Starts

2007-07-01

Expected to finish

2008-06-01

Last updated by the study team

2010-06-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of type 2 diabetes
• Hb1AC >7%-11% inclusive
• Male and females 18-70; females must be post-menopausal
• On a stable dose of metformin hydrochloride

You may not qualify if…

• Medical history of stroke, unstable angina, heart attack within one year of enrollment, and alcohol dependency or recent drug abuse.
• Women of childbearing potential, pregnant or nursing
• Evidence of diabetic complications with significant end-organ damage

Where it is running

• Pfizer Investigational Site — Gilbert, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Jonesboro, Arkansas, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Carmichael, California, United States
• Pfizer Investigational Site — Chula Vista, California, United States
• Pfizer Investigational Site — Fair Oaks, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — National City, California, United States
• Pfizer Investigational Site — Paramount, California, United States
• Pfizer Investigational Site — Roseville, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — DeFuniak Springs, Florida, United States
• Pfizer Investigational Site — Destin, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — Palm Harbor, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Conyers, Georgia, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Skokie, Illinois, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.